Literature DB >> 11798984

Management of virus-induced systemic vasculitides.

Loïc Guillevin1, Pascal Cohen.   

Abstract

The best therapeutic strategy in virus-induced vasculitides should take into account the etiology of the disease and be adapted to the pathogenesis. The combination of antiviral treatments and plasma exchanges has been proven effective in polyarteritis nodosa. In HIV-related vasculitis, this strategy is effective and does not jeopardize the outcome of AIDS, as do cytotoxic agents. In vasculitis related to hepatitis C virus-associated cryoglobulinemia, plasma exchanges improve the outcome, but the poor effectiveness of antiviral drugs usually does not favor a definite recovery of the patients. Relapses are frequent.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11798984     DOI： 10.1007/s11926-002-0025-x

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


  35 in total

1.  Successful treatment of polyarteritis nodosa related to hepatitis B virus with a combination of lamivudine and interferon alpha.

Authors:  J Wicki; J Olivieri; G Pizzolato; F Sarasin; L Guillevin; J M Dayer; C Chizzolini
Journal:  Rheumatology (Oxford)       Date:  1999-02       Impact factor: 7.580

Review 2.  Vasculitis and infection with the human immunodeficiency virus.

Authors:  L H Calabrese
Journal:  Rheum Dis Clin North Am       Date:  1991-02       Impact factor: 2.670

3.  [Periarteritis nodosa related to hepatitis B virus. Determination of a new therapeutic strategy: 13 cases].

Authors:  L Guillevin; Y Merrouche; M Gayraud; B Jarrousse; I Royer; A Léon; J Baudelot
Journal:  Presse Med       Date:  1988-09-10       Impact factor: 1.228

4.  Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients. The Cooperative Study Group for Polyarteritis Nodosa.

Authors:  L Guillevin; B Jarrousse; C Lok; F Lhote; J P Jais; D Le Thi Huong Du; A Bussel
Journal:  J Rheumatol       Date:  1991-04       Impact factor: 4.666

5.  Systemic vasculitis in patients with hepatitis C.

Authors:  P Cacoub; T Maisonobe; V Thibault; A Gatel; J Servan; L Musset; J C Piette
Journal:  J Rheumatol       Date:  2001-01       Impact factor: 4.666

6.  Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients.

Authors:  M Gayraud; L Guillevin; P le Toumelin; P Cohen; F Lhote; P Casassus; B Jarrousse
Journal:  Arthritis Rheum       Date:  2001-03

7.  Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients.

Authors:  L Guillevin; F Lhote; A Leon; F Fauvelle; L Vivitski; C Trepo
Journal:  J Rheumatol       Date:  1993-02       Impact factor: 4.666

8.  Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)

Authors:  T Poynard; P Marcellin; S S Lee; C Niederau; G S Minuk; G Ideo; V Bain; J Heathcote; S Zeuzem; C Trepo; J Albrecht
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

9.  The spectrum of vasculitis in human immunodeficiency virus-infected patients. A clinicopathologic evaluation.

Authors:  R Gherardi; L Belec; C Mhiri; F Gray; M C Lescs; A Sobel; L Guillevin; J Wechsler
Journal:  Arthritis Rheum       Date:  1993-08

10.  Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?

Authors:  T H Finkel; T J Török; P J Ferguson; E L Durigon; S R Zaki; D Y Leung; R J Harbeck; E W Gelfand; F T Saulsbury; J R Hollister
Journal:  Lancet       Date:  1994-05-21       Impact factor: 79.321
View more
  2 in total

Review 1.  Infection-related vasculitis.

Authors:  Omondi Oyoo; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

Review 2.  HIV-associated large-vessel vasculopathy: a review of the current and emerging clinicopathological spectrum in vascular surgical practice.

Authors:  Balasoobramanien Pillay; Pratistadevi K Ramdial; Datshana P Naidoo
Journal:  Cardiovasc J Afr       Date:  2015 Mar-Apr       Impact factor: 1.167
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.